Kamada (KMDA) Non-Current Assets (2012 - 2026)
Kamada (KMDA) reported Non-Current Assets of $183.8 million for Q1 2026, down 1.51% on a YoY basis from $186.6 million in Q1 2025, and down 1.0% quarter-over-quarter from $185.6 million in Q4 2025.
Kamada (KMDA) Non-Current Assets (2012 - 2026) Analysis & Trends
Kamada has reported Non-Current Assets for 13 years, with the latest figure at $183.8 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 1.51% year-over-year to $183.8 million; the trailing twelve-month figure through Mar 2026 stood at $183.8 million (down 1.51% YoY), and the FY2025 full-year result was $185.6 million, down 1.21% from the prior year.
- Non-Current Assets for Q1 2026 stood at $183.8 million, down from $185.6 million in the prior quarter.
- The five-year high for Non-Current Assets was $187.9 million in Q4 2024, with the low at $184475.0 in Q3 2022.
- Historically, Non-Current Assets has averaged $163.5 million across 5 years, with a median of $184.9 million in 2025.
- Annual changes were most pronounced in 2023 — Non-Current Assets sank 99.9% — and 2024, when it surged 99885.98%.
- Kamada's Non-Current Assets stood at $183.4 million in 2022, then increased by 0.86% to $184.9 million in 2023, then grew by 1.6% to $187.9 million in 2024, then dropped by 1.21% to $185.6 million in 2025, then fell by 1.0% to $183.8 million in 2026.
- The last three Non-Current Assets figures came in at $183.8 million (Q1 2026), $185.6 million (Q4 2025), and $184.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | 183.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 183.79 Mn |
| Dec 31, 2025 | 185.64 Mn |
| Sep 30, 2025 | 184.48 Mn |
| Jun 30, 2025 | 184.90 Mn |
| Mar 31, 2025 | 186.61 Mn |
| Dec 31, 2024 | 187.91 Mn |
| Sep 30, 2024 | 186.80 Mn |
| Jun 30, 2024 | 184.61 Mn |
| Mar 31, 2024 | 185.37 Mn |
| Dec 31, 2023 | 184.95 Mn |
| Sep 30, 2023 | 183.90 Mn |
| Jun 30, 2023 | 184.71 Mn |
| Mar 31, 2023 | 185,392.00 |
| Dec 31, 2022 | 183.37 Mn |
| Sep 30, 2022 | 184,475.00 |
| Jun 30, 2022 | 185.53 Mn |
| Mar 31, 2022 | 186.93 Mn |
| Dec 31, 2021 | 188.62 Mn |
| Sep 30, 2021 | 37.58 Mn |
| Jun 30, 2021 | 37.00 Mn |